George Peters Award

How does breast-specific gamma imaging affect the management of patients with newly diagnosed breast cancer?

Brigid K. Killelea, Alyssa Gillego, Laurie J. Kirstein, Juhi Asad, Marina Shpilko, Avni Shah, Sheldon M. Feldman, Susan K. Boolbol

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: We sought to determine the number of patients with known breast cancer who were found to have an additional, mammographically occult lesion detected on breast-specific gamma imaging (BSGI). Methods: An institutional review board-approved review of all patients who underwent BSGI at Beth Israel Medical Center from 2006 to 2008 was performed. Results: A total of 82 patients underwent BSGI for newly diagnosed breast cancer. Of these, 18 had an additional abnormality, and 17 were biopsied. There were 4 cases of invasive ductal carcinoma, 1 invasive lobular carcinoma, 1 ductal carcinoma in situ, 1 lobular carcinoma in situ, 2 papillomas, and 8 benign biopsies. One patient proceeded directly to mastectomy and an area of ductal carcinoma in situ was found, corresponding to the BSGI. Conclusions: In our study group, 22% of patients had a surgical change in management based on BSGI findings. BSGI detected additional carcinoma in 9%. BSGI plays an important role in the clinical management of patients with known breast cancer.

Original languageEnglish (US)
Pages (from-to)470-474
Number of pages5
JournalAmerican Journal of Surgery
Volume198
Issue number4
DOIs
StatePublished - Oct 1 2009
Externally publishedYes

Fingerprint

Breast
Breast Neoplasms
Carcinoma, Intraductal, Noninfiltrating
Lobular Carcinoma
Ductal Carcinoma
Research Ethics Committees
Mastectomy
Papilloma
Israel
Carcinoma
Biopsy

Keywords

  • Breast cancer
  • Breast imaging
  • Breast specific gamma imaging
  • Contralateral breast
  • Ipsilateral breast

ASJC Scopus subject areas

  • Surgery

Cite this

George Peters Award : How does breast-specific gamma imaging affect the management of patients with newly diagnosed breast cancer? / Killelea, Brigid K.; Gillego, Alyssa; Kirstein, Laurie J.; Asad, Juhi; Shpilko, Marina; Shah, Avni; Feldman, Sheldon M.; Boolbol, Susan K.

In: American Journal of Surgery, Vol. 198, No. 4, 01.10.2009, p. 470-474.

Research output: Contribution to journalArticle

Killelea, Brigid K. ; Gillego, Alyssa ; Kirstein, Laurie J. ; Asad, Juhi ; Shpilko, Marina ; Shah, Avni ; Feldman, Sheldon M. ; Boolbol, Susan K. / George Peters Award : How does breast-specific gamma imaging affect the management of patients with newly diagnosed breast cancer?. In: American Journal of Surgery. 2009 ; Vol. 198, No. 4. pp. 470-474.
@article{b3d0086a833445d1b33e8192c8bf95ab,
title = "George Peters Award: How does breast-specific gamma imaging affect the management of patients with newly diagnosed breast cancer?",
abstract = "Background: We sought to determine the number of patients with known breast cancer who were found to have an additional, mammographically occult lesion detected on breast-specific gamma imaging (BSGI). Methods: An institutional review board-approved review of all patients who underwent BSGI at Beth Israel Medical Center from 2006 to 2008 was performed. Results: A total of 82 patients underwent BSGI for newly diagnosed breast cancer. Of these, 18 had an additional abnormality, and 17 were biopsied. There were 4 cases of invasive ductal carcinoma, 1 invasive lobular carcinoma, 1 ductal carcinoma in situ, 1 lobular carcinoma in situ, 2 papillomas, and 8 benign biopsies. One patient proceeded directly to mastectomy and an area of ductal carcinoma in situ was found, corresponding to the BSGI. Conclusions: In our study group, 22{\%} of patients had a surgical change in management based on BSGI findings. BSGI detected additional carcinoma in 9{\%}. BSGI plays an important role in the clinical management of patients with known breast cancer.",
keywords = "Breast cancer, Breast imaging, Breast specific gamma imaging, Contralateral breast, Ipsilateral breast",
author = "Killelea, {Brigid K.} and Alyssa Gillego and Kirstein, {Laurie J.} and Juhi Asad and Marina Shpilko and Avni Shah and Feldman, {Sheldon M.} and Boolbol, {Susan K.}",
year = "2009",
month = "10",
day = "1",
doi = "10.1016/j.amjsurg.2009.06.016",
language = "English (US)",
volume = "198",
pages = "470--474",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - George Peters Award

T2 - How does breast-specific gamma imaging affect the management of patients with newly diagnosed breast cancer?

AU - Killelea, Brigid K.

AU - Gillego, Alyssa

AU - Kirstein, Laurie J.

AU - Asad, Juhi

AU - Shpilko, Marina

AU - Shah, Avni

AU - Feldman, Sheldon M.

AU - Boolbol, Susan K.

PY - 2009/10/1

Y1 - 2009/10/1

N2 - Background: We sought to determine the number of patients with known breast cancer who were found to have an additional, mammographically occult lesion detected on breast-specific gamma imaging (BSGI). Methods: An institutional review board-approved review of all patients who underwent BSGI at Beth Israel Medical Center from 2006 to 2008 was performed. Results: A total of 82 patients underwent BSGI for newly diagnosed breast cancer. Of these, 18 had an additional abnormality, and 17 were biopsied. There were 4 cases of invasive ductal carcinoma, 1 invasive lobular carcinoma, 1 ductal carcinoma in situ, 1 lobular carcinoma in situ, 2 papillomas, and 8 benign biopsies. One patient proceeded directly to mastectomy and an area of ductal carcinoma in situ was found, corresponding to the BSGI. Conclusions: In our study group, 22% of patients had a surgical change in management based on BSGI findings. BSGI detected additional carcinoma in 9%. BSGI plays an important role in the clinical management of patients with known breast cancer.

AB - Background: We sought to determine the number of patients with known breast cancer who were found to have an additional, mammographically occult lesion detected on breast-specific gamma imaging (BSGI). Methods: An institutional review board-approved review of all patients who underwent BSGI at Beth Israel Medical Center from 2006 to 2008 was performed. Results: A total of 82 patients underwent BSGI for newly diagnosed breast cancer. Of these, 18 had an additional abnormality, and 17 were biopsied. There were 4 cases of invasive ductal carcinoma, 1 invasive lobular carcinoma, 1 ductal carcinoma in situ, 1 lobular carcinoma in situ, 2 papillomas, and 8 benign biopsies. One patient proceeded directly to mastectomy and an area of ductal carcinoma in situ was found, corresponding to the BSGI. Conclusions: In our study group, 22% of patients had a surgical change in management based on BSGI findings. BSGI detected additional carcinoma in 9%. BSGI plays an important role in the clinical management of patients with known breast cancer.

KW - Breast cancer

KW - Breast imaging

KW - Breast specific gamma imaging

KW - Contralateral breast

KW - Ipsilateral breast

UR - http://www.scopus.com/inward/record.url?scp=70349456656&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349456656&partnerID=8YFLogxK

U2 - 10.1016/j.amjsurg.2009.06.016

DO - 10.1016/j.amjsurg.2009.06.016

M3 - Article

VL - 198

SP - 470

EP - 474

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 4

ER -